Author

D. T. Le

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Assay:imaging· 1 Organism:mouse· 1

Frequent Co-Authors

H. T. Dong· 2 shared P. Sangpo· 2 shared S. Senapin· 2 shared B. Burt· 1 shared C. Rodkhum· 1 shared C. Zalfa· 1 shared F. Kheradmand· 1 shared G. Van Buren· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPathology

H. T. Dong

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Usefulness of the pancreas as a prime target for histopathological diagnosis of Tilapia parvovirus (TiPV) infection in Nile tilapia, Oreochromis niloticus

H. T. Dong, P. Sangpo, D. T. Le, T. T. Mai, L. Nguyen Vu, J. Jorge del-Pozo, K. R. Salin, S. Senapin

This study identifies pancreatic Cowdry type A inclusion bodies as a specific histopathological marker for TiPV infection in Nile tilapia.

bioRxiv · Mar 21, 2022Pathology

Ozone nanobubble treatments improve survivability of Nile tilapia (Oreochromis niloticus) challenged with a pathogenic multidrug-resistant Aeromonas hydrophila

D. T. Le, L. V. Nguyen, H. T. Dong, C. Rodkhum, S. St. Hilaire, S. Senapin, P. Sangpo

This study shows that ozone nanobubble treatments in a recirculation system improve survival and reduce bacterial load in Nile tilapia challenged with multidrug-resistant Aeromonas hydrophila.

bioRxiv · Mar 14, 2021Microbiology

NK cells and CTLs are required to clear solid tumor in a novel model of patient-derived-xenograft

D. T. Le, B. Burt, G. Van Buren, S. A. Abeynaike, C. Zalfa, R. Nikzad, F. Kheradmand, S. Paust

This study develops a novel syngeneic immune system PDX model to show that NK cells and CTLs are required for effective immunotherapy against solid tumors.

bioRxiv · May 24, 2020 · PreprintImmunology